List of androgens/anabolic steroids available in the United States

This is a complete list of androgens/anabolic steroids (AAS) and formulations that are approved by the FDA and available in the United States. AAS like testosterone are used in androgen replacement therapy (ART), a form of hormone replacement therapy (HRT), and for other indications.

Testosterone and esters

Testosterone (unmodified/non-esterified) is available in the following formulations:

Topical gels: Androgel, Fortesta, Testim, Testosterone (generic)
Topical solutions: Axiron, Testosterone (generic)
Transdermal patches: Androderm, Testoderm (discontinued), Testoderm TTS (discontinued), Testosterone (generic)
Intranasal gels: Natesto
Buccal tablets: Striant
Pellet implants: Testopel

In addition to testosterone itself, the following ester prodrugs of testosterone are available in oil solutions for intramuscular injection:

Testosterone cypionate (Depo-Testosterone, Testosterone Cypionate (generic))
Testosterone enanthate (Delatestryl, Testosterone Enanthate (generic))
Testosterone undecanoate (Aveed)

Testosterone propionate was previously available but was discontinued. A combination of testosterone cypionate and estradiol cypionate (brand name Depo-Testadiol) and a combination of testosterone enanthate and estradiol valerate (brand name Ditate-DS) were also formerly available as oil solutions for intramuscular injection, but these formulations have been discontinued as well.

Oral testosterone undecanoate is not available in the United States.^[1]^[2] Androstanolone (dihydrotestosterone) and esters are not available in the United States.

Synthetic AAS

Oral, buccal, and/or sublingual

Fluoxymesterone (Android-F, Halotestin, Ora-Testryl)
Methyltestosterone (Android 5, Android 10, Android 25, Metandren, Oreton, Oreton Methyl, Testred, Virilon)
Oxandrolone (Oxandrin)
Oxymetholone (Anadrol-50)

(Note that while the above AAS remain available in at least one formulation, many of the above-listed brand names have been discontinued.)

Ethylestrenol (Maxibolin) and stanozolol (Winstrol) were previously available but were discontinued.

Intramuscular injection

Nandrolone decanoate (Deca-Durabolin)

Drostanolone propionate (Drolban) and nandrolone phenylpropionate (Durabolin) were previously available but were discontinued.

Weakly androgenic progestins

The following progestins are weakly androgenic and have been associated with androgenic side effects in women:

Danazol (Danocrine)
Norethisterone acetate (Aygestin, Norlutate)

Ethisterone (Pranone) was previously available but was discontinued.

Gestrinone and tibolone are also notable androgenic progestins but have never been marketed in the United States.

Notes

↑ John E. Morley; Lucretia van den Berg (5 November 1999). Endocrinology of Aging. Springer Science & Business Media. pp. 141–. ISBN 978-1-59259-715-4.
↑ Carrie Bagatell; William J. Bremner (27 May 2003). Androgens in Health and Disease. Springer Science & Business Media. pp. 144–. ISBN 978-1-59259-388-0.

References

"Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 16 November 2016.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[MorleyBerg1999-1] John E. Morley; Lucretia van den Berg (5 November 1999). Endocrinology of Aging. Springer Science & Business Media. pp. 141–. ISBN 978-1-59259-715-4.

[BagatellBremner2003-2] Carrie Bagatell; William J. Bremner (27 May 2003). Androgens in Health and Disease. Springer Science & Business Media. pp. 144–. ISBN 978-1-59259-388-0.